Skip to main content

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

This video has been developed through unrestricted educational funding from Abbott Diabetes Care.

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Jean-Pierre Riveline

Jean-Pierre Riveline is Professor of Endocrinology and Diabetology at Lariboisière Hospital in Paris, France. He is responsible for the University Center for Diabetes and its Complications (CUDC).


  • Advisory panel member for: Sanofi, MSD, Eli Lilly, Novo Nordisk, AstraZeneca, Abbott, Dexcom, Alphadiab, Insulet and Medtronic.
  • Research funding and research support: Abbott, Insulet, Medtronic, Air Liquide, Sanofi, Roche and Novo Nordisk.

Full biography